Valued Wealth Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.6K Buy
367
+54
+17% +$5.15K 0.01% 150
2026
Q2
$26.5K Buy
313
+122
+64% +$9.8K 0.01% 163
2026
Q1
$13.5K Sell
191
-42
-18% -$3.14K 0.01% 240
2025
Q4
$18.4K Buy
233
+33
+17% +$2.61K 0.01% 167
2025
Q3
$16.5K Buy
200
+10
+5% +$787 0.01% 175
2025
Q2
$15.3K Buy
190
+53
+39% +$4.09K 0.01% 172
2025
Q1
$11K Buy
137
+15
+12% +$1.25K 0.01% 212
2024
Q4
$10K Buy
122
+43
+54% +$3.58K 0.01% 228
2024
Q3
$6.52K Sell
79
-14
-15% -$1.05K ﹤0.01% 258
2024
Q2
$6.53K Buy
93
+34
+58% +$2.43K ﹤0.01% 247
2024
Q1
$4.38K Buy
59
+33
+127% +$2.3K ﹤0.01% 262
2023
Q4
$1.64K Buy
+26
New +$1.63K ﹤0.01% 326

Other funds holding MET

Valued Wealth Advisors's MET Position: Q3 2026 in Review

Valued Wealth Advisors increased its MetLife (MET) stake by 17% in Q3 2026, buying an estimated $5.15K and bringing the position to 367 shares worth $34.6K. The position accounts for 0.01% of the portfolio, ranked #150.

Valued Wealth Advisors first reported a position in MET in Q4 2023 and has held it in 12 quarters since. 832 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Valued Wealth Advisors held 367 shares of MetLife worth $34.6K as of Q3 2026.
  • Valued Wealth Advisors bought 54 MetLife shares in Q3 2026, an estimated $5.15K.
  • MetLife made up 0.01% of Valued Wealth Advisors's portfolio in Q3 2026, its #150 holding.
  • Valued Wealth Advisors first reported a position in MetLife in Q4 2023 and has held it in 12 quarters since.
  • 832 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Valued Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.